Effect of Lettuce With Different Nitrate Contents on Blood Pressure (LBP)

May 20, 2016 updated by: Newcastle University

Growth of Lettuce With Different Content of Inorganic Nitrate as a Feeding Strategy for Placebo-controlled Nutritional Interventions to Test the Effects of Inorganic Nitrate on Human Health

Leafy vegetables are a natural source of dietary nitrate, which may reduce systolic blood pressure (BP). However, the evidence has been obtained from studies using nitrate solutions (i.e., potassium or sodium nitrate) or beetroot juice supplementation which have a suitable placebo for the design of double-blind clinical trials. However, the design of food-based nutritional interventions is complicated by the fact that an appropriate placebo treatment is not available and, therefore, it is not possible to meet the criteria for proper double-blind randomised placebo-controlled intervention trials. In addition, the biological effects of processed products such as beetroot juice or solutions with a pharmacological grade may be different from that of fresh vegetables, e.g. due to conversion of nitrate to nitrite in the mouth during chewing.

Objectives: to investigate whether two sets of lettuce specifically grown with different nitrate content but otherwise similar composition show different effects on nitrate uptake and bioavailability in humans. Additionally, the investigators also aim to design human intervention studies to investigate the effect of intake of lettuce with different nitrate content on vascular health.

These objectives will be tested by growing lettuce with different fertiliser compositions resulting in high and low nitrate content and then investigating the bioavailability and short-term effect on BP in healthy young volunteers in a double-blind cross-over design. Eligible subjects will consume one meal each of either low or high nitrate lettuce. Urine, blood and saliva samples will be collected at baseline, for 6 hours after the ingestion and then again after 24hr. Blood Pressure BP will be measured continuously for 24 hours starting at baseline. The volunteers will repeat the intervention with the second treatment.

Study Overview

Detailed Description

Study Design and Subjects: This study is designed as a double-blind, randomized, crossover, intervention trial in which thirty healthy young volunteers (BMI: 20-25 kg/m2), non-smoking subjects (age: 18-35 years) will be recruited. In each of two intervention periods, subjects will be asked to eat 50g of either high nitrate lettuce or low nitrate lettuce (placebo) on a single occasion (the second visit) with dietary restriction for 3 days prior to the second visit and in the 24 hr period following after the consumption, concluded with a third visit, with at least 3 weeks washout period before the second 2-day intervention period. Urine, saliva and blood samples will be collected during a 6-hour period during the second visit. Urine samples will be collected during 24h from consumption until the third visit, to assess the pharmacokinetics and bioavailability and compliance to the interventions (details in the diagram of human trial).

The primary outcomes are 24-hour BP and nitrate content in urine, plasma and saliva. Samples will be collected into tubes and then analysed in the laboratory for the nitrate content (NO3-) by gas chromatography-mass spectroscopy (GCMS). Participants will follow specific dietary and lifestyle instructions to minimise confounding effects.

Participant will receive a small honorarium after the study and reasonable travel expenses will be reimbursed.

Dietary Interventions: Participants will be asked to arrive fasting in the morning of the second (main) visit and will consume a standard meal (Chicken Hotpot from ASDA) with the same drink water at the evening before and the evening after the visit, as well as following a diet that excludes a list of specific foods containing high nitrate (rocket, spinach, other leafy vegetables, radish and beet root), cured meat, cured seafood and cured fish, mature cheese for 24hr prior to the study and fasting on the morning of the study.

Anthropometry: This includes the measurements of body weight, height and waist circumference according to standardised protocols. Procedures are safe, not invasive and induce minimal discomfort for the participants.

Body Composition: This includes the measurement of body fat and muscle using a non-invasive technique called bio impedance analysis using a leg-to-leg bioelectrical impedance device (TANITA 300 MA). The procedure is safe, non-invasive and induces minimal discomfort for the participant. The duration of the measurement is of approximately 3-5 minutes.

24-hr BP monitoring: participants will be fitted with an automated portable device to measure BP over a 24-hr period. Participants will be instructed on how to safely operate the device. The measurement are safe and minimally invasive. BP readings will be recorded every 30 minutes during day time and every hour during the night to minimise the potential impact on sleep quality.

Urine samples: The first morning void (FMV) will be collected at home (pre supplementation) and after arrival full urine samples (all that the volunteer is able to produce) at set times before and after the supplementation (between baseline and 6hr) at NU-Food research facility. Subsequent collections afterwards (between 6-12hr and 12-24 hr) will take place at home in appropriate plastic containers and the samples will be collected at the final visit 24hr after the consumption. After measuring the volume of each sample, sub samples will be stored for analysis and for calculation of pharmacokinetics.

Saliva samples: a small saliva sample (~2ml) will be collected in disposable plastic containers at baseline and at every hour for 6 hours at NU-Food research facility; and then after 9 and 12 hour at home, with the final sample taken after 24 hr.

Blood Samples: Venous blood samples (LH 6 ml) will be collected at baseline, three and six hours post supplementation of treatments and then again after 24 hr.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Phase 2
  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • England
      • Newcastle upon Tyne, England, United Kingdom, NE1
        • School of Agriculture, Food and Rural Development

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 31 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria:

The investigators aim to recruit 20 healthy young volunteers, non-smoking, male and female aged 18-35 years with a body mass index (BMI) in the range of 20 to 25 kg/m2.

Exclusion criteria (reason for exclusion):

  • Current participation in other clinical investigations.
  • Mouthwash users.
  • Vegetarianism (likely to have very high nitrate intake)
  • Dislike to lettuce consumption or inability to comply with the study diet (lack of compliance)
  • Use of antihypertensive or cholesterol lowering medication.
  • History of any major illness such as cancer; or cholesterol lowering medication; history of cardiovascular or peripheral vascular disease;
  • History of any major illness such as cancer; a psychiatric illness; recent history of asthma, renal, liver or gastrointestinal disease.
  • Use of antibiotics within previous 2 months; current or recent (within previous 6 months) significant weight loss or gain (>6% of body weight); --woman who were pregnant, lactating or wishing to become pregnant during the study.
  • Previous diagnosis of type 1 or type-2 diabetes treated with insulin (modification of regulation of intermediate metabolism).
  • Major surgical operations interfering with the study outcomes (systemic effects on study outcomes).
  • Alcohol intake >21 units/week for men and >14 units/week women
  • Non English speakers or volunteers requiring translators or interpreters (since these services are not available for this study).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Low nitrate lettuce
50g of low nitrate lettuce (placebo) on single occasions
The lettuce has been grown with low concentration of nitrogen fertilizer (25ppm) to produce the low amount of nitrate in the lettuce, the nitrate content of 50 grams of high nitrate lettuce was (~3 mg nitrate derived).
Active Comparator: High nitrate lettuce
50g of high nitrate lettuce (intervention) on single occasions
The lettuce has been grown with high concentration of nitrogen fertilizer (150ppm) to produce the high of nitrate content in the lettuce, the nitrate content of 50 grams of high nitrate lettuce was (~530 mg nitrate derived).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in 24-hour Ambulatory Blood Pressure (AMBP)
Time Frame: Baseline and 24 hours
Change in Systolic and Diastolic Blood Pressure at baseline and every 30 minutes at day time and every hour at night time for 24 hours.
Baseline and 24 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in bio-availability of nitrate and nitrite in plasma
Time Frame: 24 hours
Change in plasma nitrate and nitrite at baseline, 3 hours, 6 hours and 24 hours from intervention.
24 hours
Change in Cyclic Guanosine Monophosphate (cGMP) in plasma samples
Time Frame: 24 hours
Change in Cyclic Guanosine Monophosphate (cGMP) in plasma samples at baseline, 3 hours, 6 hours and 24 hours from intervention.
24 hours
Change in bio-availability of nitrate and nitrite in urine samples
Time Frame: 24 hours
Change in urinary nitrate and nitrite at baseline, 0-3, 3-6, 6-12 and 12-24 hours from intervention.
24 hours
Change in bio-availability of nitrate and nitrite in saliva samples
Time Frame: 24 hours
Change in salivary nitrate and nitrite at baseline, 0, 1, 2, 3, 4, 5, 6, 9, 12 and 24 hours from intervention.
24 hours
Change in Antioxidant capacity of Ferric Reducing Antioxidant Power (FRAP) and Trolox Equivalent Antioxidant Capacity (TEAC) in plasma samples.
Time Frame: 24 hours
Change in Antioxidant capacity of Ferric Reducing Antioxidant Power (FRAP) and Trolox Equivalent Antioxidant Capacity (TEAC) in plasma samples at baseline, 3 hours, 6 hours and 24 hours from intervention.
24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: AFRD School, School of Agriculture, Food and Rural Development

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2015

Primary Completion (Actual)

August 1, 2015

Study Completion (Actual)

August 1, 2015

Study Registration Dates

First Submitted

February 17, 2016

First Submitted That Met QC Criteria

March 2, 2016

First Posted (Estimate)

March 8, 2016

Study Record Updates

Last Update Posted (Estimate)

May 23, 2016

Last Update Submitted That Met QC Criteria

May 20, 2016

Last Verified

May 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • 15-QAD-15

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

I can't share the individual participants data because of the privacy of volunteers have been participated in this study and this already been mentioned in the application form of ethical approval.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Blood Pressure

Clinical Trials on Low Nitrate Lettuce

Subscribe